Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 105
- Uncategorized
Colorado’s Cannabis Sales Surpass $15bn But Slowdown Continues
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- CBD Market
FSA’s New CBD Guidance ‘Heavy Handed’ and Likely to Leave Consumers and Businesses ‘Confused’ Says Industry
Yesterday, the UK’s Food Standards Agency (FSA) published new guidance on the safe limit of CBD which can be ingested daily, significantly reducing the figure from 70mg to 10mg.
- CBD Market
FSA Drops Recommended Daily Dose of CBD to 10MG – Everything You Need to Know
Co-written by Business of Cannabis and Cannabis Health The UK’s Food Standards Agency (FSA) today published a shock update to its consumer guidance on the recommended daily dosage of CBD.
- Uncategorized
New York’s Cannabis Growers Showcases are ‘Absolutely Pivotal’ for Independent Cultivators
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Markets & Stocks
Northern Leaf ‘Very Confident’ IPO Will Launch This Year, Chill Brands’ Shares Jump On WHSmith Deal
Northern Leaf Jersey-based medical cannabis cultivator Northern Leaf have said they are ‘very confident’ of launching an AIM listing in Q4 this year.
- Policy & Regulation
Cannabis Industry ‘Debanking’ Survey Launched
A survey to understand the scale of UK cannabis industry banking challenges has been launched by the Cannabis Industry Council (CIC).
- Uncategorized
Business of Cannabis Launches #BUYLOCALNY Campaign in Partnership with Cannabis Association of New York (CANY)
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- Opinion
Data Is the New Fertiliser for Profitable Cannabis Cultivation and Legalisation
Swiss cannabis management software company Cannavigia, whose product is currently being utilised by cultivators and across the Swiss pilot programmes, recently announced that it had hired a new Chief Commercial Officer (CCO), Timo Bongartz.
- Press releases
Oxford Cannabinoid Technologies Publishes Phase I Clinical Trial Results for Lead Drug Candidate
Oxford Cannabinoid Technologies Holdings plc (LSE: OCTP), the pharmaceutical company developing prescription cannabinoid medicines, is pleased to announce that dosing of all the cohorts of the Phase I, single ascending dose study for OCT461201 has been successfully completed.
- Uncategorized
Massachusetts’s Suspended Cannabis Chair Drops Lawsuit
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.
- CBD Market
Italian Court Temporarily Blocks Reclassification of CBD as a Narcotic, but Industry Warns It’s ‘Just the Beginning of a Long Struggle’
Italy’s CBD industry claimed another ‘important success’ last week as the recent ministerial decree that threatened to reclassify CBD oil as a narcotic substance was temporarily suspended.
- Uncategorized
Kentucky Governor Provides Update on Long-Awaited Medical Cannabis Programme
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel.












